日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma

转移性乳头状肾细胞癌一线治疗临床疗效的真实世界评估

De Vries-Brilland, Manon; Hamilou, Zineb; Ghosh, Sunita; Heng, Daniel Y C; Wood, Lori A; Basappa, Naveen S; Kollmannsberger, Christian K; Graham, Jeffrey; Bhindi, Bimal; Finelli, Antonio; Bjarnason, Georg A; Bosse, Dominick; Pouliot, Frederic; Castonguay, Vincent; Breau, Rodney H; Saleh, Ramy R; Winquist, Eric; Lalani, Aly-Khan A; Soulières, Denis

A Rare Case of Metastatic Urethral Squamous Cell Carcinoma Presenting with Paraneoplastic Sweet Syndrome and Treated with Pembrolizumab

一例罕见的转移性尿道鳞状细胞癌病例,表现为副肿瘤性Sweet综合征,并接受了帕博利珠单抗治疗

Nguyen, Dan-Thanh Christine; Hamilou, Zineb; Bonnardeaux, Evelyne; Blais, Normand; de Vries-Brilland, Manon

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update)

2025年加拿大泌尿外科协会-加拿大泌尿肿瘤学会指南:转移性去势抵抗性前列腺癌(更新)

Saad, Fred; So, Alan I; Aprikian, Armen; Finelli, Antonio; Fleshner, Neil E; Gleave, Martin E; Hamilou, Zineb; Niazi, Tamim; North, Scott A; Pouliot, Frédéric; Rendon, Ricardo A; Shayegan, Bobby; Sridhar, Srikala S; Usmani, Nawaid; Vigneault, Eric; Chi, Kim N

Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors

专家对接受PARP抑制剂治疗的前列腺癌患者贫血管理的意见

Hanna, Lilian; O'Dwyer, Richard; Hamilou, Zineb; Noonan, Krista; Doucette, Sarah; Sridhar, Srikala S

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

通过三示踪剂PET成像确定mCRPC患者的患者内转移灶间异质性及其与生存率的相关性:3TMPO队列研究

Pouliot, Frédéric; Saad, Fred; Rousseau, Etienne; Richard, Patrick O; Zamanian, Atefeh; Probst, Stephan; Lévesque, Éric; Castonguay, Vincent; Marcoux, Nicolas; Lodde, Michele; Juneau, Daniel; Hamilou, Zineb; Lattouf, Jean-Baptiste; Buteau, François-Alexandre; Pavic, Michel; Castilloux, Jean-François; Neveu, Bertrand; Bouvet, Guillaume F; Allard, Catherine; Tétu, Amélie; Guérin, Brigitte; Beauregard, Jean-Mathieu

Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada

HER2阳性转移性乳腺癌三线治疗模式:加拿大真实世界数据的回顾性分析

Gambaro, Karen; Groleau, Mélanie; McNamara, Suzan; Awan, Arif; Salem, Maged; Abdelsalam, Mahmoud; St-Hilaire, Eve; Vincent, François; Carrier, Julie; MacKay, Helen; Provencher, Louise; Boudreau, Dominique; Hamilou, Zineb; Saad, Fred; Ferrario, Cristiano; Batist, Gerald; Marques, Maud

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context

加拿大背景下转移性前列腺癌伴DNA修复基因改变患者的识别和管理考量

Kolinsky, Michael P; Niederhoffer, Karen Y; Kwan, Edmond M; Hotte, Sebastien J; Hamilou, Zineb; Yip, Steven M; Chi, Kim N; Wyatt, Alexander W; Saad, Fred

A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer

单中心多学科团队运用氯化镭-223治疗转移性去势抵抗性前列腺癌的经验

Charrois-Durand, Cédric; Saad, Fred; Barkati, Maroie; Lattouf, Jean-Baptiste; Perrotte, Paul; Karakiewicz, Pierre I; Soulières, Denis; Blais, Normand; Hamilou, Zineb; Juneau, Daniel; Plouznikoff, Nicolas; Taussky, Daniel; Delouya, Guila

Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?

对于接受局部治疗后PSA升高的前列腺癌患者,是否应采用雄激素剥夺疗法和其他全身性治疗方法?

Patrikidou, Anna; Zilli, Thomas; Baciarello, Giulia; Terisse, Safae; Hamilou, Zineb; Fizazi, Karim

Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada

脐尿管癌的治疗:加拿大泌尿外科协会和加拿大泌尿生殖系统肿瘤内科医生协会的共识声明

Hamilou, Zineb; North, Scott; Canil, Christina; Wood, Lori; Hotte, Sebastien; Sridhar, Srikala S; Soulières, Denis; Latour, Mathieu; Taussky, Daniel; Kassouf, Wassim; Blais, Normand